Transcriptomic effect of Anethole trithione (ATT) on human BPH-1 cells
Ontology highlight
ABSTRACT: The goal of this experiment was to evaluate the effect of antioxidant treatment on the transcriptome of epithelial cells from human benign prostate hyperplasia (BPH).
The BPH-1 cell line has been immortalized from a 68-year-old BPH patient using SV-40 T-antigen (Hayward et al 1995, In Vitro Cell Dev Biol Anim 31, 14-24). BPH-1 cells were purchased in 2019 at DSMZ-German collection (ACC 143, reference 1402) and maintained in DMEM medium (Gibco, GlutamaxTM, 4.5g/L D-Glucose + Pyruvate, reference 31966-0.21) with 10% FBS (Eurobio, CVFSVF00-01). Anethole trithione (ATT) is an antioxidant molecule acting as a specific inhibitor of reactive oxygen species (ROS) production at the Iq site of the mitochondrial respiratory chain (Detaille et al, PLoS One 14, e0216385). ATT was initially resuspended at 10 mM in Dimethyl Sulfoxide (DMSO, Sigma D4540-500ML) then diluted in culture medium.
For this experiment, 2 million BPH-1 cells were seeded in 100mm Petri dish. Media was replaced 24h after seeding, then fresh medium containing 10 µM ATT or vehicle (same dilution of DMSO without ATT) was added for 72h. Cells were trypsinized and centrifuged to dry pellets were stored at -20°C. RNA was extracted using NucleoSpin (Macherey Nagel) according to the manufacturer’s protocol and quantified using Nanodrop 2000 (Thermo Scientific). RNA quality was checked with Bioanalyser 2100 (Agilent), then 5µL RNA at a concentration of 120ng/µl were used for library generation. Clariom_S_Human arrays were used on the GeneChip 3000 7G scanner (Thermo Fisher Scientific). Results were processed with Transcriptome Analysis Console TAC4.0 (Thermo Fisher Scientific) and normalized with summarization methods RMA.
ORGANISM(S): Homo sapiens (human)
SUBMITTER:
PROVIDER: S-BSST1129 | biostudies-other |
REPOSITORIES: biostudies-other
ACCESS DATA